A chronic autoimmune disease, rheumatoid arthritis (RA) is characterized by persistent inflammation of the synovial membrane and progressive joint destruction. Beyond loss of mobility, sufferers face a high risk of heart failure. A new study indicates that anti-TNF therapy does a patient’s heart more good than harm, when it successfully reduces the inflammatory toll of RA.